Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1995
05/26/1995WO1995014006A1 OCTAHYDROBENZO[f]QUINOLINE-BASED RECEPTOR AGONISTS AND ANTAGONISTS
05/26/1995WO1995014005A1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants
05/26/1995WO1995014004A1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d
05/26/1995WO1995013834A1 Chimeric oligonucleoside compounds
05/26/1995WO1995013833A1 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
05/26/1995WO1995013820A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
05/26/1995WO1995013818A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
05/26/1995WO1995013816A1 Transdermal prostaglandin composition
05/26/1995WO1995013815A1 Combination method for the treatment of patterned alopecia
05/26/1995WO1995013814A1 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
05/26/1995WO1995013813A1 Aminoanthraquinone derivatives to combat multidrug resistance
05/26/1995WO1995013812A1 Use of substituted 1,4-dihydropyridine to reduce intraocular pressure
05/26/1995WO1995013811A1 Use of substituted thiazolidine derivatives in the treatment of raised intraocular pressure
05/26/1995WO1995013810A1 Nasal spray compositions containing oxymetazoline
05/26/1995WO1995013809A1 Use of phorbine ring derived photosensitizer compounds for the decontamination of parasite and/or virus-infected blood
05/26/1995WO1995013808A1 Method for selectively inhibiting il-2 signal transduction
05/26/1995WO1995013806A1 Compositions containing zinc linoleate for the treatment of skin disorders
05/26/1995WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995WO1995013802A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
05/26/1995WO1995013801A1 Fatty acid delivery system
05/26/1995WO1995013800A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995WO1995013799A1 Preparation of biodegradable microparticles containing a biologically active agent
05/26/1995WO1995013798A1 Controlled release preparation
05/26/1995WO1995013797A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995WO1995013795A1 Hydrophobic preparations
05/26/1995WO1995013792A1 Cosmetic method for treatment of skin
05/26/1995WO1995013790A1 Non-irritating cosmetic compositions
05/26/1995WO1995013789A1 Cosmetic method for treatment of skin
05/26/1995WO1995013767A1 Osteogenic product and process
05/26/1995WO1995013701A1 Novel fas protein and methods of use thereof
05/26/1995WO1995001168A3 Pharmaceutical preparations that contain an active substance with modified amidine groups
05/26/1995WO1994027584A3 Arylating medicaments
05/26/1995CA2177046A1 Octahydrobenzo[f]quinoline-based receptor agonists and antagonists
05/26/1995CA2176933A1 Controlled release preparation
05/26/1995CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995CA2176760A1 Anti-viral guanidino-substituted compounds
05/26/1995CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176727A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995CA2176721A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
05/26/1995CA2176585A1 Recombinant adenoviruses for gene therapy in cancers
05/26/1995CA2176577A1 Hydrophobic preparations
05/26/1995CA2176575A1 Novel fas protein and methods of use thereof
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2176498A1 Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
05/26/1995CA2176372A1 Chirally enriched synthetic phosphonate oligomers
05/26/1995CA2176259A1 Chimeric oligonucleoside compounds
05/26/1995CA2176220A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
05/26/1995CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995CA2176044A1 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2176043A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2176041A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2176014A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
05/26/1995CA2175813A1 Cosmetic method for treatment of skin
05/26/1995CA2175812A1 Non-irritating cosmetic compositions
05/26/1995CA2175676A1 Cosmetic method for treatment of skin
05/26/1995CA2175386A1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants
05/26/1995CA2175350A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995CA2174650A1 Piperidinyl camphorsulfonyl oxytocin antagonists
05/26/1995CA2174649A1 Prodrugs of an inhibitor of hiv protease
05/26/1995CA2174124A1 Pyrone derivatives as protease inhibitors and antiviral agents
05/26/1995CA2169643A1 Substituted 5-ring heterocycles, their preparation and their use
05/26/1995CA2136661A1 Use of 1-{4-[4-aryl (or heteroaryl)-1-peperazinyl]-butyl}-1 -h-azole derivatives in the preparation of drugs used for treating gastric secretion disorders
05/25/1995CA2109895A1 Nicotine containing oral preparation
05/24/1995EP0654484A2 Pharmaceutical compositions containing inclusion compounds of thioctic or dihydroliponic acid with cyclodextrins and in granule form or in chewable or effervescent tablet form
05/24/1995EP0654479A2 Esculetin derivatives and method for manufacture thereof, use thereof, and pharmaceutical composition
05/24/1995EP0654471A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and process for preparing the same
05/24/1995EP0654467A2 Vitamin D3 analogs
05/24/1995EP0654269A1 Medicinal composition for inhibiting cancer metastasis to liver and medicinal composition for curing hepatoma
05/24/1995EP0654268A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1
05/24/1995EP0654267A1 Carcinostatic for hormonotheraphy containing dienogest as effective component
05/24/1995EP0654266A1 Cardiac protective
05/24/1995EP0654265A1 Aromatase-inhibiting composition containing azole derivative
05/24/1995EP0654264A1 Treatment of incontinence with venlafaxine or an aryloxy propanamine compound
05/24/1995EP0654263A1 Sustained release composition and a method of preparing pharmaceutical compositions
05/24/1995EP0654262A1 A mixture of higher primary aliphatic alcohols, its obtained from beeswax and its pharmaceutical use
05/24/1995EP0654077A1 Method and reagent for treatment of animal diseases
05/24/1995EP0654047A1 Glucans with immunostimulant activity
05/24/1995EP0654037A1 Antiretroviral enantiomeric nucleotide analogs
05/24/1995EP0654036A1 Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs.
05/24/1995EP0654033A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties
05/24/1995EP0654031A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
05/24/1995EP0654029A1 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
05/24/1995EP0654027A1 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists
05/24/1995EP0654024A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
05/24/1995EP0654023A1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists
05/24/1995EP0653943A1 Targeting somatic gene therapy to joints
05/24/1995EP0653937A1 Chemical compounds
05/24/1995EP0653911A1 Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
05/24/1995EP0630238A4 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa).
05/24/1995EP0604560A4 Human cyclin e.
05/24/1995EP0586392B1 Method for separating a vegetable compound
05/24/1995EP0500802B1 Liposomal compositions
05/24/1995EP0460143B1 Rolipram-containing composition for transdermal application
05/24/1995EP0417254B1 Production of beta-1,3-glucan in algae
05/24/1995EP0381700B1 The use of a fructooligosaccharid in the manufacture of a bacteriostatic composition for inhibiting the growth of Salmonella and a process for inhibiting the growth of Salmonella in a food animal
05/24/1995EP0357630B1 Combination of minoxidil and an anti-inflammatory agent for treating patterned alopecia
05/24/1995DE4430154A1 Antidepressant for ocular or nasal admin.
05/24/1995DE4339848A1 Compsn. contg. lithium salts and angiotensin-II-receptor antagonists
1 ... 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 7032 7033 7034 7035 7036 ... 7860